3.8 Proceedings Paper

Increasing the Accuracy of Optipharm's Virtual Screening Predictions by Implementing Molecular Flexibility

期刊

出版社

SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/978-3-031-07802-6_20

关键词

Ligand based virtual screening; Molecule's flexibility; Optimization

资金

  1. Spanish Ministry of Economy and Competitiveness [CTQ2017-87974-R, RTI2018-095993-B-I00, EQC2019-006418-P]
  2. Junta de Andalucia [P18-RT-1193]
  3. Programa Regional de Fomento de la Investigacion (Plan de Actuacion 2018, Region de Murcia, Spain) [20988/PI/18]
  4. University of Almeria [UAL18-TIC-A020-B]
  5. European Union (NextGenerationEU) [RR A 2021 21]

向作者/读者索取更多资源

OptiPharm is a new software that optimizes the similarity of molecules and competes well with other algorithms. However, all methods, including OptiPharm, assuming proteins as rigid can lead to inaccurate predictions. This study extends OptiPharm's functionality by considering molecular flexibility, introducing improvements that enhance prediction accuracy.
Recently, a new piece of software called OptiPharm has been proposed to optimize the similarity between two given molecules. A comprehensive study proved it was very competitive compared with state-of-the-art algorithms such as WEGA and ROCS. However, all of these methods, including OptiPharm, assume the proteins as rigid, resulting in poor or inefficient predictions. The consideration of conformational changes and thus the molecule's flexibility is necessary. In this work, we have extended the OptiPharm's functionality by applying a methodology that considers the flexibility of the molecules. Apart from that, the new OptiPharm presents some strengths regarding its previous version. More precisely, it reduces the search space dimension and introduces circular limits for the angular variables to enhance searchability. As results will show, these improvements help OptiPharm to achieve better predictions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据